CareDx Inc (CDNA) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $53.83 (-0.83%), Market cap $1.05B, 52-week low–high $11.57 ~ $22.42.
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune quiescence, active injury, acute cellular rejection, and antibody mediated rejection; HistoMap Kidney, a sol
Financial statements, price targets, institutional (13F) holdings and related news for CareDx Inc are updated in real time on BlackAll Trade.
CareDx Inc trades at $53.83 (-0.83%). Real-time quotes and charts are available on BlackAll Trade.
CareDx Inc has a market cap of about $1.05B.
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derive